Plasma copper and the risk of first stroke in hypertensive patients: a nested case-control study

Jingping Zhang, Jingjing Cao, Hao Zhang, Chongfei Jiang, Tengfei Lin, Ziyi Zhou, Yun Song, Youbao Li, Chengzhang Liu, Lishun Liu, Binyan Wang, Genfu Tang, Jianping Li, Yan Zhang, Yimin Cui, Yong Huo, Yan Yang, Wenhua Ling, Jingang Yang, Huiyuan GuoXiaobin Wang, Xiping Xu, Xianhui Qin

Research output: Contribution to journalArticle

Abstract

Background: Previous studies indicated that trace elements may play an important role in cardiovascular diseases. However, data concerning the association between blood copper and the risk of stroke are limited. Objective: The aim of this study was to evaluate the association between plasma copper and the risk of first stroke, and examine any possible effect modifiers in hypertensive patients. Methods: We conducted a nested case-control study, using data from the China Stroke Primary Prevention Trial. Hypertension is defined as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg, or taking antihypertensive medication. A total of 618 first stroke cases and 618 controls matched for age, sex, treatment group, and study site were included in this study. The crude and adjusted risks of first stroke were estimated by ORs and 95% CIs using conditional logistic regression, without or with adjusting for pertinent covariates, respectively. Results: There were significant positive associations of plasma copper with risk of first stroke (per SD increment-OR: 1.20; 95% CI: 1.03, 1.39) and first ischemic stroke (OR: 1.26; 95% CI: 1.07, 1.50).When plasma copperwas categorized in quartiles, significantly higher risks of first stroke (OR: 1.72; 95% CI: 1.12, 2.65) and first ischemic stroke (OR: 1.91; 95% CI: 1.18, 3.11) were found in participants in quartile 4 (≥ 117.0 μg/dL) than in those in quartile 1 (< 91.2 μg/dL). Furthermore, the plasma copper-first stroke association was significantly stronger in participants with higher BMI (< 25.0 compared with ≥ 25.0 kg/m2, P-interaction = 0.024). However, there was no significant association between plasma copper and first hemorrhagic stroke. Conclusions: In Chinese hypertensive patients, there was a significant positive association between baseline plasma copper and the risk of first stroke, especially among those with higher BMI. This trial was registered at clinicaltrials.gov as NCT00794885.

Original languageEnglish (US)
Article numbernzq099
Pages (from-to)212-220
Number of pages9
JournalAmerican Journal of Clinical Nutrition
Volume110
Issue number1
DOIs
StatePublished - Jul 1 2019

Fingerprint

Case-Control Studies
Copper
Stroke
Blood Pressure
Trace Elements
Primary Prevention
Antihypertensive Agents
China
Cardiovascular Diseases
Logistic Models
Hypertension

Keywords

  • Body mass index
  • Copper
  • First ischemic stroke
  • First stroke
  • Hypertensive patients

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Plasma copper and the risk of first stroke in hypertensive patients : a nested case-control study. / Zhang, Jingping; Cao, Jingjing; Zhang, Hao; Jiang, Chongfei; Lin, Tengfei; Zhou, Ziyi; Song, Yun; Li, Youbao; Liu, Chengzhang; Liu, Lishun; Wang, Binyan; Tang, Genfu; Li, Jianping; Zhang, Yan; Cui, Yimin; Huo, Yong; Yang, Yan; Ling, Wenhua; Yang, Jingang; Guo, Huiyuan; Wang, Xiaobin; Xu, Xiping; Qin, Xianhui.

In: American Journal of Clinical Nutrition, Vol. 110, No. 1, nzq099, 01.07.2019, p. 212-220.

Research output: Contribution to journalArticle

Zhang, J, Cao, J, Zhang, H, Jiang, C, Lin, T, Zhou, Z, Song, Y, Li, Y, Liu, C, Liu, L, Wang, B, Tang, G, Li, J, Zhang, Y, Cui, Y, Huo, Y, Yang, Y, Ling, W, Yang, J, Guo, H, Wang, X, Xu, X & Qin, X 2019, 'Plasma copper and the risk of first stroke in hypertensive patients: a nested case-control study', American Journal of Clinical Nutrition, vol. 110, no. 1, nzq099, pp. 212-220. https://doi.org/10.1093/ajcn/nqz099
Zhang, Jingping ; Cao, Jingjing ; Zhang, Hao ; Jiang, Chongfei ; Lin, Tengfei ; Zhou, Ziyi ; Song, Yun ; Li, Youbao ; Liu, Chengzhang ; Liu, Lishun ; Wang, Binyan ; Tang, Genfu ; Li, Jianping ; Zhang, Yan ; Cui, Yimin ; Huo, Yong ; Yang, Yan ; Ling, Wenhua ; Yang, Jingang ; Guo, Huiyuan ; Wang, Xiaobin ; Xu, Xiping ; Qin, Xianhui. / Plasma copper and the risk of first stroke in hypertensive patients : a nested case-control study. In: American Journal of Clinical Nutrition. 2019 ; Vol. 110, No. 1. pp. 212-220.
@article{37bfc99a49bb4a59833ab4b91950b3fb,
title = "Plasma copper and the risk of first stroke in hypertensive patients: a nested case-control study",
abstract = "Background: Previous studies indicated that trace elements may play an important role in cardiovascular diseases. However, data concerning the association between blood copper and the risk of stroke are limited. Objective: The aim of this study was to evaluate the association between plasma copper and the risk of first stroke, and examine any possible effect modifiers in hypertensive patients. Methods: We conducted a nested case-control study, using data from the China Stroke Primary Prevention Trial. Hypertension is defined as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg, or taking antihypertensive medication. A total of 618 first stroke cases and 618 controls matched for age, sex, treatment group, and study site were included in this study. The crude and adjusted risks of first stroke were estimated by ORs and 95{\%} CIs using conditional logistic regression, without or with adjusting for pertinent covariates, respectively. Results: There were significant positive associations of plasma copper with risk of first stroke (per SD increment-OR: 1.20; 95{\%} CI: 1.03, 1.39) and first ischemic stroke (OR: 1.26; 95{\%} CI: 1.07, 1.50).When plasma copperwas categorized in quartiles, significantly higher risks of first stroke (OR: 1.72; 95{\%} CI: 1.12, 2.65) and first ischemic stroke (OR: 1.91; 95{\%} CI: 1.18, 3.11) were found in participants in quartile 4 (≥ 117.0 μg/dL) than in those in quartile 1 (< 91.2 μg/dL). Furthermore, the plasma copper-first stroke association was significantly stronger in participants with higher BMI (< 25.0 compared with ≥ 25.0 kg/m2, P-interaction = 0.024). However, there was no significant association between plasma copper and first hemorrhagic stroke. Conclusions: In Chinese hypertensive patients, there was a significant positive association between baseline plasma copper and the risk of first stroke, especially among those with higher BMI. This trial was registered at clinicaltrials.gov as NCT00794885.",
keywords = "Body mass index, Copper, First ischemic stroke, First stroke, Hypertensive patients",
author = "Jingping Zhang and Jingjing Cao and Hao Zhang and Chongfei Jiang and Tengfei Lin and Ziyi Zhou and Yun Song and Youbao Li and Chengzhang Liu and Lishun Liu and Binyan Wang and Genfu Tang and Jianping Li and Yan Zhang and Yimin Cui and Yong Huo and Yan Yang and Wenhua Ling and Jingang Yang and Huiyuan Guo and Xiaobin Wang and Xiping Xu and Xianhui Qin",
year = "2019",
month = "7",
day = "1",
doi = "10.1093/ajcn/nqz099",
language = "English (US)",
volume = "110",
pages = "212--220",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "1",

}

TY - JOUR

T1 - Plasma copper and the risk of first stroke in hypertensive patients

T2 - a nested case-control study

AU - Zhang, Jingping

AU - Cao, Jingjing

AU - Zhang, Hao

AU - Jiang, Chongfei

AU - Lin, Tengfei

AU - Zhou, Ziyi

AU - Song, Yun

AU - Li, Youbao

AU - Liu, Chengzhang

AU - Liu, Lishun

AU - Wang, Binyan

AU - Tang, Genfu

AU - Li, Jianping

AU - Zhang, Yan

AU - Cui, Yimin

AU - Huo, Yong

AU - Yang, Yan

AU - Ling, Wenhua

AU - Yang, Jingang

AU - Guo, Huiyuan

AU - Wang, Xiaobin

AU - Xu, Xiping

AU - Qin, Xianhui

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Background: Previous studies indicated that trace elements may play an important role in cardiovascular diseases. However, data concerning the association between blood copper and the risk of stroke are limited. Objective: The aim of this study was to evaluate the association between plasma copper and the risk of first stroke, and examine any possible effect modifiers in hypertensive patients. Methods: We conducted a nested case-control study, using data from the China Stroke Primary Prevention Trial. Hypertension is defined as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg, or taking antihypertensive medication. A total of 618 first stroke cases and 618 controls matched for age, sex, treatment group, and study site were included in this study. The crude and adjusted risks of first stroke were estimated by ORs and 95% CIs using conditional logistic regression, without or with adjusting for pertinent covariates, respectively. Results: There were significant positive associations of plasma copper with risk of first stroke (per SD increment-OR: 1.20; 95% CI: 1.03, 1.39) and first ischemic stroke (OR: 1.26; 95% CI: 1.07, 1.50).When plasma copperwas categorized in quartiles, significantly higher risks of first stroke (OR: 1.72; 95% CI: 1.12, 2.65) and first ischemic stroke (OR: 1.91; 95% CI: 1.18, 3.11) were found in participants in quartile 4 (≥ 117.0 μg/dL) than in those in quartile 1 (< 91.2 μg/dL). Furthermore, the plasma copper-first stroke association was significantly stronger in participants with higher BMI (< 25.0 compared with ≥ 25.0 kg/m2, P-interaction = 0.024). However, there was no significant association between plasma copper and first hemorrhagic stroke. Conclusions: In Chinese hypertensive patients, there was a significant positive association between baseline plasma copper and the risk of first stroke, especially among those with higher BMI. This trial was registered at clinicaltrials.gov as NCT00794885.

AB - Background: Previous studies indicated that trace elements may play an important role in cardiovascular diseases. However, data concerning the association between blood copper and the risk of stroke are limited. Objective: The aim of this study was to evaluate the association between plasma copper and the risk of first stroke, and examine any possible effect modifiers in hypertensive patients. Methods: We conducted a nested case-control study, using data from the China Stroke Primary Prevention Trial. Hypertension is defined as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg, or taking antihypertensive medication. A total of 618 first stroke cases and 618 controls matched for age, sex, treatment group, and study site were included in this study. The crude and adjusted risks of first stroke were estimated by ORs and 95% CIs using conditional logistic regression, without or with adjusting for pertinent covariates, respectively. Results: There were significant positive associations of plasma copper with risk of first stroke (per SD increment-OR: 1.20; 95% CI: 1.03, 1.39) and first ischemic stroke (OR: 1.26; 95% CI: 1.07, 1.50).When plasma copperwas categorized in quartiles, significantly higher risks of first stroke (OR: 1.72; 95% CI: 1.12, 2.65) and first ischemic stroke (OR: 1.91; 95% CI: 1.18, 3.11) were found in participants in quartile 4 (≥ 117.0 μg/dL) than in those in quartile 1 (< 91.2 μg/dL). Furthermore, the plasma copper-first stroke association was significantly stronger in participants with higher BMI (< 25.0 compared with ≥ 25.0 kg/m2, P-interaction = 0.024). However, there was no significant association between plasma copper and first hemorrhagic stroke. Conclusions: In Chinese hypertensive patients, there was a significant positive association between baseline plasma copper and the risk of first stroke, especially among those with higher BMI. This trial was registered at clinicaltrials.gov as NCT00794885.

KW - Body mass index

KW - Copper

KW - First ischemic stroke

KW - First stroke

KW - Hypertensive patients

UR - http://www.scopus.com/inward/record.url?scp=85068601373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068601373&partnerID=8YFLogxK

U2 - 10.1093/ajcn/nqz099

DO - 10.1093/ajcn/nqz099

M3 - Article

C2 - 31161196

AN - SCOPUS:85068601373

VL - 110

SP - 212

EP - 220

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 1

M1 - nzq099

ER -